Jiangsu Nhwa Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 28.06%

Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has an Asset Resilience Ratio of 28.06% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥2.71 Billion

≈ $395.97 Million USD Cash + Short-term Investments

Total Assets

CN¥9.64 Billion

≈ $1.41 Billion USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Jiangsu Nhwa Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check Jiangsu Nhwa Pharmaceutical Co Ltd (002262) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Jiangsu Nhwa Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002262 stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥2.71 Billion	28.06%
Total Liquid Assets	CN¥2.71 Billion	28.06%

Asset Resilience Insights

Very High Liquidity: Jiangsu Nhwa Pharmaceutical Co Ltd maintains exceptional liquid asset reserves at 28.06% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Jiangsu Nhwa Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jiangsu Nhwa Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Jiangsu Nhwa Pharmaceutical Co Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Jiangsu Nhwa Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	27.85%	CN¥2.57 Billion ≈ $375.93 Million	CN¥9.22 Billion ≈ $1.35 Billion	-0.26pp
2024-12-31	28.12%	CN¥2.37 Billion ≈ $347.24 Million	CN¥8.44 Billion ≈ $1.24 Billion	+9.90pp
2023-12-31	18.22%	CN¥1.33 Billion ≈ $195.35 Million	CN¥7.33 Billion ≈ $1.07 Billion	-4.19pp
2022-12-31	22.40%	CN¥1.45 Billion ≈ $212.47 Million	CN¥6.48 Billion ≈ $948.40 Million	+3.83pp
2021-12-31	18.58%	CN¥1.06 Billion ≈ $154.88 Million	CN¥5.70 Billion ≈ $833.68 Million	+1.18pp
2020-12-31	17.39%	CN¥837.00 Million ≈ $122.48 Million	CN¥4.81 Billion ≈ $704.17 Million	+15.73pp
2019-12-31	1.67%	CN¥70.00 Million ≈ $10.24 Million	CN¥4.20 Billion ≈ $614.81 Million	-1.68pp
2018-12-31	3.35%	CN¥135.00 Million ≈ $19.75 Million	CN¥4.03 Billion ≈ $590.13 Million	-6.83pp
2017-12-31	10.18%	CN¥336.05 Million ≈ $49.17 Million	CN¥3.30 Billion ≈ $483.12 Million	+6.14pp
2016-12-31	4.03%	CN¥120.00 Million ≈ $17.56 Million	CN¥2.97 Billion ≈ $435.32 Million	--

pp = percentage points

About Jiangsu Nhwa Pharmaceutical Co Ltd

SHE:002262 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.30 Billion

CN¥22.58 Billion CNY

Market Cap Rank

#4589 Global

#733 in China

Share Price

CN¥22.23

Change (1 day)

+0.59%

52-Week Range

CN¥18.23 - CN¥28.92

All Time High

CN¥31.19